624398564	624398564	CD	B-NP	O
|	|	NN	I-NP	O
NH	NH	NN	I-NP	O
|	|	NN	I-NP	O
45944850	45944850	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9182650	9182650	CD	B-NP	O
|	|	CC	I-NP	O
9/23/2006	9/23/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
2/2	2/2	CD	I-NP	O
oral	oral	JJ	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
stopping	stop	VBG	B-VP	O
lasix	lasix	CD	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/1/2006	4/1/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/19/2006	8/19/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
ISERI	ISERI	NNP	B-NP	O
,	,	,	O	O
CHADWICK	CHADWICK	NNP	B-NP	O
029-69-05-4	029-69-05-4	CD	I-NP	O
Ton	Ton	NNP	I-NP	O
Wa	Wa	NNP	I-NP	O
Eclaathens	Eclaathens	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/5/06	10/5/06	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
basic	basic	JJ	I-NP	O
labs	lab	NNS	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KAST	KAST	NNP	B-NP	O
,	,	,	O	O
SAL	SAL	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/23	3/23	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/26/06	2/26/06	CD	B-NP	O
by	by	IN	B-PP	O
LUDECKE	LUDECKE	NNP	B-NP	O
,	,	,	O	O
ORVILLE	ORVILLE	NNP	B-NP	O
BUD	BUD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/26/06	2/26/06	CD	B-NP	O
by	by	IN	B-PP	O
BACKENSTOSE	BACKENSTOSE	NNP	B-NP	O
,	,	,	O	O
JESSE	JESSE	NNP	B-NP	O
D	D	NNP	I-NP	O
DELMAR	DELMAR	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
069812382	069812382	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/26/06	2/26/06	CD	B-NP	O
by	by	IN	B-PP	O
POPPLETON	POPPLETON	NNP	B-NP	O
,	,	,	O	O
BRYON	BRYON	NNP	B-NP	O
E	E	NNP	I-NP	O
TORY	TORY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
069812382	069812382	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
ATENOLOL	ATENOLOL	NNP	B-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/8	9/8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
NOW	NOW	NNP	I-NP	O
,	,	,	O	O
Within	Within	NNP	B-NP	O
Hour	Hour	NNP	I-NP	O
of	of	IN	B-PP	O
Pharmacy	Pharmacy	NNP	B-NP	O
Approval	Approval	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/26/06	2/26/06	CD	B-NP	O
by	by	IN	B-PP	O
KENNEALLY	KENNEALLY	NNP	B-NP	O
,	,	,	O	O
VALENTINE	VALENTINE	NNP	B-NP	O
A	A	NNP	I-NP	O
SYLVESTER	SYLVESTER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
230494262	230494262	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/26/06	2/26/06	CD	B-NP	O
by	by	IN	B-PP	O
BADAGLIACCA	BADAGLIACCA	NNP	B-NP	O
,	,	,	O	O
SCOT	SCOT	NNP	B-NP	O
BUD	BUD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
CLARITIN	CLARITIN	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
LORATADINE	LORATADINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
FLOVENT	FLOVENT	NN	I-NP	B-protein
HFA	HFA	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FLUTICASONE	FLUTICASONE	NN	I-NP	I-protein
PROPIONATE	PROPIONATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
110	110	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
9/8	9/8	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	O	I-protein
ATORVASTATIN	ATORVASTATIN	NN	B-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/26/06	2/26/06	CD	B-NP	O
by	by	IN	B-PP	O
DURATE	DURATE	NNP	B-NP	O
,	,	,	O	O
MILO	MILO	NNP	B-NP	O
P	P	NNP	I-NP	O
ANTONIA	ANTONIA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
069812382	069812382	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/26/06	2/26/06	CD	B-NP	O
by	by	IN	B-PP	O
SHIPES	SHIPES	NNP	B-NP	O
,	,	,	O	O
WELDON	WELDON	NNP	B-NP	O
GUADALUPE	GUADALUPE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ATORVASTATIN	ATORVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
351395851	351395851	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
MUSCLE	MUSCLE	NNP	B-NP	O
ACHE	ACHE	NNP	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
on	on	IN	B-PP	O
atorvastatin	atorvastatin	NN	B-NP	O
and	and	CC	I-NP	O
tolerates	tolerate	NNS	I-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
simvastatin	simvastatin	NN	B-NP	B-protein
CELEXA	CELEXA	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CITALOPRAM	CITALOPRAM	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
30	30	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
NEXIUM	NEXIUM	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
9/8	9/8	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
IRON	IRON	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
DUONEB	DUONEB	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
AND	AND	CC	I-NP	O
IPRATROPIUM	IPRATROPIUM	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PULMICORT	PULMICORT	NN	I-NP	O
RESPULES	RESPULES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BUDESONIDE	BUDESONIDE	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
SUSP	SUSP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.25	0.25	CD	I-NP	O
MG	MG	NN	I-NP	O
INH	INH	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gram	gram	NN	I-NP	O
K	K	NN	I-NP	O
+	+	SYM	B-NP	O
,	,	,	O	O
Renal	Renal	JJ	B-NP	O
diet	diet	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
Elevate	Elevate	NN	I-NP	O
feet	foot	NNS	I-NP	O
with	with	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
sitting	sit	VBG	B-VP	O
Walking	Walking	NNP	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Rittenberry	Rittenberry	NNP	I-NP	O
pcp	pcp	NN	I-NP	O
2/11	2/11	CD	I-NP	O
@	@	NN	I-NP	O
9	9	CD	B-NP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Mura	Mura	NNP	I-NP	O
renal	renal	JJ	I-NP	O
10/20	10/20	CD	I-NP	O
@	@	NN	I-NP	O
2	2	CD	B-NP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Bausman	Bausman	NNP	I-NP	O
card	card	NN	I-NP	O
2/1	2/1	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
,	,	,	O	O
emc	emc	NN	B-NP	O
anticoag	anticoag	NN	I-NP	O
107-568-5779	107-568-5779	CD	B-NP	O
clinic	clinic	NN	I-NP	O
will	will	MD	B-VP	O
contact	contact	VB	I-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/28	7/28	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Wisotzkey	Wisotzkey	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
SULFUR	SULFUR	NNP	B-NP	O
,	,	,	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
,	,	,	O	O
Codeine	Codeine	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Hyperkalemia	Hyperkalemia	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
2/2	2/2	CD	I-NP	O
oral	oral	JJ	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
stopping	stop	VBG	B-VP	O
lasix	lasix	CD	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
IMI	IMI	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
RCA	RCA	NNP	I-NP	O
angioplasty	angioplasty	JJ	I-NP	O
s/p	s/p	NN	I-NP	O
pacer	pacer	NN	I-NP	O
for	for	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
prostate	prostate	NN	I-NP	O
cancer	cancer	NN	I-NP	O
s/p	s/p	NN	I-NP	O
XRT	XRT	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
afib	afib	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
kayexalate	kayexalate	NN	I-NP	O
,	,	,	O	O
IVF	IVF	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Called	Call	VBN	B-VP	O
to	to	TO	I-VP	O
come	come	VB	I-VP	O
in	in	RP	B-PRT	O
for	for	IN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
81	81	CD	B-NP	O
YO	YO	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
3/11	3/11	CD	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
feeling	feel	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Labwork	Labwork	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
andelevated	andelevated	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
3.4	3.4	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
over	over	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
give	give	VBP	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
recently	recently	RB	B-ADVP	O
on	on	IN	B-PP	O
ECHO	ECHO	NN	B-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
for	for	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
today	today	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
repeat	repeat	NN	B-NP	O
lab	lab	NN	I-NP	O
work	work	VB	B-VP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
to	to	TO	B-PP	O
2.3	2.3	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
baseline	baseline	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
6.3	6.3	CD	B-NP	O
from	from	IN	B-PP	O
6.0	6.0	CD	B-NP	O
3/11	3/11	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-VP	O
come	come	VB	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
ED.In	ED.In	NNP	I-NP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
his	his	PRP$	B-NP	O
VS	VS	NN	I-NP	O
showed	show	VBD	B-VP	O
T	T	NN	B-NP	O
:	:	:	O	O
96	96	CD	B-NP	O
HR	HR	NN	I-NP	O
:	:	:	O	O
60	60	CD	B-NP	O
RR	RR	NN	I-NP	O
:	:	:	O	O
16	16	CD	B-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
101/58	101/58	CD	B-NP	O
SaO2	SaO2	CD	I-NP	O
:	:	:	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
kayexalate	kayexalate	NN	B-NP	O
60	60	CD	I-NP	O
X	X	SYM	I-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
medicine	medicine	NN	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
care.On	care.On	NN	I-NP	O
further	further	JJ	I-NP	O
history	history	NN	I-NP	O
he	he	PRP	B-NP	O
notes	note	VBZ	B-VP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
eating	eat	VBG	I-VP	O
one	one	CD	B-NP	O
banana	banana	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
and	and	CC	O	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
glass	glass	NN	I-NP	O
of	of	IN	B-PP	O
orange	orange	NN	B-NP	O
juice	juice	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
eating	eat	VBG	I-VP	O
oranges	orange	NNS	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
recent	recent	JJ	I-NP	O
medication	medication	NN	I-NP	O
changes	change	NNS	I-NP	O
or	or	CC	I-NP	O
NSAID	NSAID	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
he	he	PRP	B-NP	O
states	state	VBZ	B-VP	O
he	he	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
denies	deny	VBZ	B-VP	O
acute	acute	JJ	B-NP	O
complaintsROS	complaintsROS	NN	I-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
visual	visual	JJ	B-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
hearing	hear	VBG	B-VP	O
change	change	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
,	,	,	O	O
neck	neck	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
neck	neck	NN	B-NP	O
stiffness	stiffness	NN	I-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
or	or	CC	O	O
bladder	bladder	NN	B-NP	O
incontinance	incontinance	NN	I-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
sensory	sensory	JJ	B-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
hematuria	hematuria	NN	B-NP	O
,	,	,	O	O
rash	rash	NN	B-NP	O
,	,	,	O	O
other	other	JJ	B-NP	O
joint	joint	JJ	I-NP	O
pains	pain	NNS	I-NP	O
PMH	PMH	NN	I-NP	B-protein
:	:	:	O	I-protein
1	1	CD	B-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Ischemic	Ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
-	-	HYPH	O	O
EF	EF	NN	B-NP	B-protein
by	by	IN	B-PP	O
ECHO	ECHO	NN	B-NP	O
11/20/2006	11/20/2006	CD	I-NP	O
60-65	60-65	CD	I-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
improved	improve	VBN	B-VP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	B-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
IMI	IMI	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
.	.	.	O	O

MIBI	MIBI	NN	B-NP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
defects3	defects3	NN	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

ICD	ICD	NN	B-NP	B-protein
PPM4	PPM4	NN	I-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

CVA	CVA	NN	B-NP	O
with	with	IN	B-PP	O
transient	transient	JJ	B-NP	O
amnesia	amnesia	NN	I-NP	O
in	in	IN	B-PP	O
19915	19915	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
in	in	IN	B-PP	O
past	past	JJ	B-ADJP	O
now	now	RB	B-ADVP	O
in	in	IN	B-PP	O
NSR6	NSR6	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NN	B-NP	B-protein

Asthma7	Asthma7	NN	B-NP	B-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Prostate	Prostate	NN	B-NP	B-protein
cancer	cancer	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
radiation8	radiation8	NN	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Hypertension9	Hypertension9	NN	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Hyperlipidemia10	Hyperlipidemia10	NN	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Gastritis11	Gastritis11	NN	B-NP	B-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Allergic	Allergic	JJ	B-NP	O
rhinitis12	rhinitis12	NN	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Gout13	Gout13	NN	B-NP	B-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Depression14	Depression14	NN	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Chronic	Chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
diseasea	diseasea	NN	I-NP	O
.	.	.	O	O

Seen	Seen	NNP	B-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Familia	Familia	NNP	I-NP	O
10/13/2006b	10/13/2006b	NN	I-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
2.2-2	2.2-2	CD	I-NP	O
.8	.8	CD	I-NP	O
--	--	:	O	O
MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

ASA	ASA	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
daily2	daily2	NN	I-NP	O
.	.	.	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Atenolol	Atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
daily3	daily3	NN	I-NP	O
.	.	.	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Isosorbide	Isosorbide	NN	B-NP	O
dinitrate	dinitrate	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
TID4	TID4	NN	I-NP	O
.	.	.	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Atorvastatin	Atorvastatin	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
daily5	daily5	NN	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
daily6	daily6	NN	I-NP	O
.	.	.	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Coumadin	Coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
daily7	daily7	NN	I-NP	O
.	.	.	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Allopurinol	Allopurinol	DT	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
daily8	daily8	NN	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Flovent	Flovent	NN	B-NP	B-protein
110	110	CD	I-NP	I-protein
mcg	mcg	NN	I-NP	I-protein
BID9	BID9	NN	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Nasonex10	Nasonex10	NN	B-NP	B-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Claritin	Claritin	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
daily11	daily11	NN	I-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Celexa	Celexa	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
daily12	daily12	NN	I-NP	O
.	.	.	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
daily	daily	JJ	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
SULFA	SULFA	NN	B-NP	B-protein
`	`	``	I-NP	O
rashCODEINE	rashCODEINE	NN	I-NP	O
`	`	``	I-NP	O
rash	rash	NN	I-NP	O
SHX	SHX	NN	I-NP	O
:	:	:	O	O
Retired	Retire	VBN	B-NP	O
VP	VP	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
insurance	insurance	NN	I-NP	O
company	company	NN	I-NP	O
.	.	.	O	O

Married	Marry	VBN	B-VP	O
with	with	IN	B-PP	O
six	six	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ETOH	ETOH	NN	I-NP	B-protein
or	or	CC	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
FHX	FHX	NN	I-NP	O
:	:	:	O	O
Non-contributory	Non-contributory	JJ	B-ADJP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
VS	VS	NN	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
:	:	:	O	O
96	96	CD	B-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
101/58	101/58	CD	B-NP	O
HR	HR	NN	I-NP	O
:	:	:	O	O
100	100	CD	B-NP	O
RR	RR	NN	I-NP	O
:	:	:	O	O
16	16	CD	B-NP	O
HR	HR	NN	I-NP	O
:	:	:	O	O
60	60	CD	B-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
laying	lay	VBG	B-VP	O
on	on	IN	B-PP	O
stretcher	stretch	JJR	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
anicteric	anicteric	JJ	B-NP	O
sclerae	sclerae	NNS	I-NP	O
,	,	,	O	O
mmm	mmm	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
oral	oral	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
or	or	CC	O	O
thrush	thrush	VB	B-VP	O
NECK	NECK	NNP	B-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
adenopathy	adenopathy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
JVD	JVD	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
CHEST	CHEST	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	B-protein
bilaterally	bilaterally	RB	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
NT	NT	NN	I-NP	O
,	,	,	O	O
ND	ND	NN	B-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
present	present	JJ	B-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
edema	edema	NN	B-NP	O
SKIN	SKIN	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
rash	rash	NN	I-NP	O
NEURO	NEURO	NN	I-NP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBD	B-VP	O
X	X	SYM	B-NP	B-DNA
3	3	CD	I-NP	I-DNA
,	,	,	O	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficit	deficit	NN	I-NP	O
of	of	IN	B-PP	O
strength	strength	NN	B-NP	O
or	or	CC	I-NP	O
sensation	sensation	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
81	81	CD	B-NP	O
YO	YO	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
called	call	VBN	I-VP	O
with	with	IN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
on	on	IN	B-PP	O
labs	lab	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
has	have	VBZ	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
after	after	IN	B-PP	O
holding	hold	VBG	B-VP	O
his	his	PRP$	B-NP	O
diuretic	diuretic	JJ	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
reveals	reveal	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
ACEi	ACEi	NNP	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
CKD	CKD	NN	B-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Hyperkalemia	Hyperkalemia	NN	B-NP	O
on	on	IN	B-PP	O
labwork	labwork	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
over	over	IN	B-PP	O
night	night	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
at	at	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

ACEI	ACEI	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
dietary	dietary	JJ	B-NP	O
education	education	NN	I-NP	O
for	for	IN	B-PP	O
low	low	JJ	B-NP	O
K	K	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
90mg	90mg	NN	B-NP	O
of	of	IN	B-PP	O
kayexalate	kayexalate	NN	B-NP	O
and	and	CC	I-NP	O
K	K	NN	I-NP	O
is	be	VBZ	B-VP	O
5.8	5.8	CD	B-NP	O
post	post	NN	I-NP	O
60mg	60mg	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
4.3	4.3	CD	B-NP	O
on	on	IN	B-PP	O
4/8	4/8	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
without	without	IN	B-PP	O
ACEI	ACEI	NN	B-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
w	w	NN	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
ISCHEMIA	ISCHEMIA	NN	B-NP	O
:	:	:	O	O
Known	Know	VBN	B-NP	O
CAD	CAD	NN	I-NP	B-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
7	7	CD	I-NP	O
Continue	Continue	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
7	7	CD	I-NP	O
Continue	Continue	NNP	I-NP	O
atenolol	atenolol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
consider	consider	VBP	B-VP	O
changing	change	VBG	I-VP	O
to	to	TO	B-PP	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
given	give	VBN	B-VP	O
renal	renal	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
7	7	CD	I-NP	O
Continue	Continue	NNP	I-NP	O
statin	statin	NN	I-NP	O
7	7	CD	B-NP	O
Nitrates	Nitrate	NNS	I-NP	O
per	per	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
PUMP	PUMP	NN	I-NP	O
:	:	:	O	O
Euvolemic	Euvolemic	JJ	B-ADJP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
with	with	IN	B-PP	O
preserved	preserve	VBN	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
on	on	IN	B-PP	O
last	last	JJ	B-NP	O
ECHO	ECHO	NN	I-NP	O
7	7	CD	I-NP	O
I/O	I/O	NN	I-NP	O
and	and	CC	O	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
7	7	CD	I-NP	O
Will	Will	NNP	I-NP	O
restart	restart	VB	B-VP	O
ACEI	ACEI	NNP	B-NP	O
given	give	VBN	B-VP	O
improved	improve	VBD	B-VP	O
potassium	potassium	NN	B-NP	O
7	7	CD	I-NP	O
Restart	Restart	NNP	I-NP	O
lower	low	JJR	I-NP	O
dose	dose	NN	I-NP	O
lasix	lasix	NN	I-NP	O
of	of	IN	B-PP	O
40mg	40mg	CD	B-NP	O
qd	qd	NN	I-NP	O
RHYTHM	RHYTHM	NNP	I-NP	O
:	:	:	O	O
History	History	NN	B-NP	B-protein
AF	AF	NN	I-NP	I-protein
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

AV	AV	NN	B-NP	O
paced	pace	VBN	B-VP	O
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
ICD	ICD	NN	B-NP	B-protein
.	.	.	O	O

Had	Have	VBD	B-VP	O
?	?	.	O	O

brady	brady	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
to	to	TO	B-PP	O
30s	30s	CD	B-NP	O
and	and	CC	I-NP	O
40s	40s	CD	I-NP	O
per	per	IN	B-PP	O
nursing	nursing	NN	B-NP	O
but	but	CC	B-PP	O
on	on	IN	B-PP	O
looking	look	VBG	B-VP	O
at	at	IN	B-PP	O
tele	tele	NN	B-NP	O
w	w	NN	I-NP	O
EP	EP	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
is	be	VBZ	B-VP	O
paced	pace	VBN	I-VP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
.	.	.	O	O

So	So	RB	B-ADVP	O
no	no	DT	B-NP	O
interrogation	interrogation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
AICD	AICD	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
-LRB-	-LRB-	NNP	B-NP	O
last	last	JJ	B-ADJP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
November	November	NNP	B-NP	O
05	05	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7	7	CD	I-NP	O
Continue	Continue	NNP	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
7	7	CD	I-NP	O
Continue	Continue	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
2-3	2-3	NN	I-NP	O
GOUT	GOUT	NN	I-NP	O
:	:	:	O	O
Currently	Currently	RB	B-NP	O
asymptomatic	asymptomatic	JJ	I-NP	O
-	-	HYPH	I-NP	O
continue	continue	JJ	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
per	per	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
HEME	HEME	NN	I-NP	B-protein
:	:	:	O	O
Anemia	Anemia	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
workup	workup	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Hct	Hct	NN	B-NP	O
drop	drop	NN	I-NP	O
from	from	IN	B-PP	O
34	34	CD	B-NP	O
-	-	HYPH	B-ADJP	O
>	>	SYM	B-NP	O
29	29	CD	I-NP	O
.	.	.	O	O

Repeated	Repeat	VBN	B-NP	O
Hct	Hct	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
31	31	CD	B-NP	O
.	.	.	O	O

Likely	Likely	RB	B-ADVP	O
Hct	Hct	NNP	B-NP	O
drop	drop	NN	I-NP	O
from	from	IN	B-PP	O
34	34	CD	B-NP	O
--	--	:	O	O
>	>	SYM	O	O
29	29	CD	B-NP	O
is	be	VBZ	B-VP	O
from	from	IN	B-PP	O
dehydration/rehydration	dehydration/rehydration	NN	B-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
studies	study	NNS	I-NP	O
c/w	c/w	VBP	B-VP	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
.	.	.	O	O

Reticulocytes	Reticulocyte	NNS	B-NP	O
high	high	JJ	B-ADJP	O
-	-	HYPH	O	O
14	14	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Needs	Need	NNS	B-NP	O
GI	GI	NN	I-NP	O
w/u	w/u	NN	I-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
Flovent	Flovent	NNP	I-NP	O
.	.	.	O	O

Started	Started	JJ	B-NP	O
pulmicort	pulmicort	NN	I-NP	O
per	per	IN	B-PP	O
pulm	pulm	NN	B-NP	O
clinic	clinic	NN	I-NP	O
note	note	NN	I-NP	O
as	as	IN	B-PP	O
occasionally	occasionally	RB	B-ADJP	O
wheezy	wheezy	JJ	I-ADJP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
,	,	,	I-NP	O
low	low	JJ	I-NP	O
sodium	sodium	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
liter	liter	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restricted	restricted	JJ	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
Lytes	Lytes	NNP	B-NP	O
BID	BID	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
's	'	VBZ	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
PPX	PPX	NN	I-NP	O
:	:	:	O	O
Pneumoboots	Pneumoboot	NNS	B-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
PPI	PPI	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
per	per	IN	B-PP	O
family	family	NN	B-NP	O
's	's	POS	B-NP	O
request	request	NN	I-NP	O
given	give	VBN	B-VP	O
frequent	frequent	JJ	B-NP	O
falls	fall	NNS	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
adhere	adhere	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
K	K	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
measure	measure	VB	B-VP	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

please	please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Daily	Daily	JJ	B-NP	O
labs	lab	NNS	I-NP	O
for	for	IN	B-PP	O
K	K	NN	B-NP	O
,	,	,	O	O
hct	hct	NN	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	O
x3	x3	NN	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
q3d	q3d	NN	B-NP	O
until	until	IN	B-PP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Discharge	Discharge	NN	B-NP	O
hct	hct	NN	I-NP	O
29.5	29.5	CD	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
forward	forward	JJ	B-NP	O
lab	lab	NN	I-NP	O
results	result	NNS	I-NP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Moros	Moros	NNP	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	NN	B-NP	O
RH	RH	NN	I-NP	O
if	if	IN	B-SBAR	O
hct	hct	NN	B-NP	O
<	<	SYM	B-NP	O
27	27	CD	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
page	page	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Monte	Monte	NNP	I-NP	O
Basket	Basket	NNP	I-NP	O
V	V	NNP	I-NP	O
#	#	#	B-NP	O
47789	47789	CD	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Daily	Daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
,	,	,	O	O
make	make	VB	B-VP	O
sure	sure	JJ	B-ADJP	O
pt	pt	NN	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
volume	volume	NN	B-NP	B-protein
overloaded	overload	VBD	B-VP	I-protein
3	3	CD	B-NP	I-protein
.	.	.	O	O

Monitor	Monitor	NN	B-NP	B-protein
vital	vital	JJ	I-NP	I-protein
signs	sign	NNS	I-NP	I-protein
4	4	CD	B-NP	I-protein
.	.	.	O	O

PT/OT	PT/OT	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Started	Start	VBN	B-NP	O
duoneb	duoneb	NN	I-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
decrease	decrease	VB	I-VP	O
to	to	TO	I-VP	O
prn	prn	VB	I-VP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
days	day	NNS	I-NP	O
if	if	IN	B-SBAR	O
breathing	breathing	NN	B-NP	O
remains	remain	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
PCP	PCP	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
with	with	IN	B-PP	O
fe-deficient	fe-deficient	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
diverticulae	diverticulae	VBP	B-VP	O
on	on	IN	B-PP	O
anticoag	anticoag	NN	B-NP	O
,	,	,	O	O
hct	hct	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
started	start	VBD	B-VP	O
iron	iron	NN	B-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
retics	retic	NNS	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
GI	GI	NN	B-NP	O
w/u	w/u	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SANFELIX	SANFELIX	NNP	B-NP	O
,	,	,	O	O
GINO	GINO	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OX961	OX961	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/5/06	10/5/06	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
47	47	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

